294 Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy

MLA

Miettinen, K., et al. “294 Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients with Dilated Cardiomyopathy.” European Journal of Heart Failure. Supplements, vol. 5, no. 1, June 2006, p. 68. EBSCOhost, https://doi.org/10.1016/S1567-4215(06)80196-7.

APA

Miettinen, K., Eriksson, S., Magga, J., Tuomainen, P., Vanninen, E., Punnonen, K., Pettersson, K., & Peuhkurinen, K. (2006). 294 Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. European Journal of Heart Failure. Supplements, 5(1), 68. https://doi.org/10.1016/S1567-4215(06)80196-7

Chicago

Miettinen, K., S. Eriksson, J. Magga, P. Tuomainen, E. Vanninen, K. Punnonen, K. Pettersson, and K. Peuhkurinen. 2006. “294 Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients with Dilated Cardiomyopathy.” European Journal of Heart Failure. Supplements 5 (1): 68. doi:10.1016/S1567-4215(06)80196-7.